Repligen Corp (NASDAQ: RGEN) stock closed at $125.94 on 6/13/24 after a major decline of -11.8%. Moreover, exceptionally high trading volume at 383% of normal accompanied the decline. The stock has declined -16.4% during the last week and has performed in line with the market over the last nine months.
Current PriceTarget Research Rating
RGEN is expected to continue to be a modest Value Builder reflecting capital returns that are forecasted to exceed the cost of capital.
Repligen has a current Value Trend Rating of D (Negative). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing contradictory signals. Repligen has a poor Appreciation Score of 17 but a slightly positive Power Rating of 63, resulting in the Negative Value Trend Rating.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment